Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Why the stock rally fizzled - plus, our latest thinking on Goldman and Bristol Myers

C3.ai, Inc. (NYSE:AI) Q4 2025 Earnings Call Transcript

Fairtree Asset Management Pty Ltd Invests $550,000 in Bristol-Myers Squibb (NYSE:BMY)

Chancellor Financial Group WB LP Purchases Shares of 8,673 Bristol-Myers Squibb (NYSE:BMY)

111 Capital Purchases New Holdings in Bristol-Myers Squibb (NYSE:BMY)

Two Sigma Investments LP Sells 4,635,617 Shares of Bristol-Myers Squibb (NYSE:BMY)

Rutgers student's internship at Goldman Sachs leads to full-time job offer | Morningstar

Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications | Morningstar

Bristol Myers Gets European Approval for Subcutaneous Opdivo | Morningstar

Halozyme Says Bristol-Myers Squibb Gets EC Approval For Opdivo SC Developed With Halozyme's ENHANZE

Top Startup and Tech Funding News - May 27, 2025

Leigh Baldwin & CO. LLC Makes New $534,000 Investment in Bristol-Myers Squibb (NYSE:BMY)

294,400 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Polar Asset Management Partners Inc.

Forum Financial Management LP Acquires 5,462 Shares of Bristol-Myers Squibb (NYSE:BMY)

Ascent Group LLC Increases Position in Bristol-Myers Squibb (NYSE:BMY)

49,748 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by GF Fund Management CO. LTD.

Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial

Is It Crohn's or Ulcerative Colitis? IBD Types Are Similar but Not the Same

Hall Capital Management Co. Inc. Purchases Shares of 5,815 Bristol-Myers Squibb (NYSE:BMY)

10,000 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Aurdan Capital Management LLC

Leigh Baldwin & CO. LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)

846 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Fourth Dimension Wealth LLC

Vise Technologies Inc. Has $2.54 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)

JT Stratford LLC Buys 22,929 Shares of Bristol-Myers Squibb (NYSE:BMY)

Inspire Trust Co. N.A. Sells 45,500 Shares of Bristol-Myers Squibb (NYSE:BMY)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Increases Stake in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stock Holdings Decreased by Public Employees Retirement System of Ohio

Css LLC Il Raises Stake in Bristol-Myers Squibb (NYSE:BMY)

Tidal Investments LLC Has $5.10 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Waverly Advisors LLC Purchases 18,722 Shares of Bristol-Myers Squibb (NYSE:BMY)

Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 3,196,919 Shares of Bristol-Myers Squibb (NYSE:BMY)

Wesleyan Assurance Society Sells 9,811 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Woodline Partners LP

Multiple Myeloma Market Size 2024-2035, Epidemiology, Treatment & Companies

Leica Biosystems and Bristol Myers Squibb Announce Strategic Partnership to Drive Innovation in Companion Diagnostics and Enable Precision Medicine | PressReleasePoint

In silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations

USS Investment Management Ltd Sells 46,833 Shares of Bristol-Myers Squibb (NYSE:BMY)

St. Clair Advisors LLC Buys New Shares in Bristol-Myers Squibb (NYSE:BMY)

Triglav Skladi D.O.O. Buys Shares of 28,900 Bristol-Myers Squibb (NYSE:BMY)

Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer

Trump's MFN model may erode Big pharma's 50% US profits, analysts suggest

Zurich Insurance Group Ltd FI Purchases 422,804 Shares of Bristol-Myers Squibb (NYSE:BMY)

Texas Bank & Trust Co Purchases New Position in Bristol-Myers Squibb (NYSE:BMY)

Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic | The Manila Times

Blending Traditional and Digital: How Brand Insiders Engage Today's Consumers 05/20/2025

Bristol Myers Squibb patents new BCL-6 degradation inducers | BioWorld

Suvretta Capital Management LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Two Sigma Advisers LP

Siemens Fonds Invest GmbH Sells 44,507 Shares of Bristol-Myers Squibb (NYSE:BMY)

Thornburg Investment Management Inc. Reduces Holdings in Bristol-Myers Squibb (NYSE:BMY)

Rafferty Asset Management LLC Acquires 21,714 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb patents new USP1 inhibitors | BioWorld

Progressive Pulmonary Fibrosis Slows With Novel Agent

Stonebrook Private Inc. Purchases 276 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stock Unloaded Sen. Tommy Tuberville

Second Line Capital LLC Sells 1,944 Shares of Bristol-Myers Squibb (NYSE:BMY)

Second Line Capital LLC Cuts Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Shell Asset Management Co.

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by ProShare Advisors LLC

Bristol-Myers Squibb (NYSE:BMY) Stake Boosted by Point72 Asia Singapore Pte. Ltd.

Polar Asset Management Partners Inc. Acquires Shares of 294,400 Bristol-Myers Squibb (NYSE:BMY)

Quantinno Capital Management LP Acquires 54,104 Shares of Bristol-Myers Squibb (NYSE:BMY)

NorthRock Partners LLC Purchases 17,672 Shares of Bristol-Myers Squibb (NYSE:BMY)

Mufg Securities Americas Inc. Invests $1.69 Million in Bristol-Myers Squibb (NYSE:BMY)

Nuveen Asset Management LLC Purchases 1,444,822 Shares of Bristol-Myers Squibb (NYSE:BMY)

Dividend Discounts: 5 Cheap Stocks Yielding Up to 7.6%

Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration

Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial

Tumour and microenvironment crosstalk in NSCLC progression and response to therapy

Polar Asset Management Partners Inc. Buys Shares of 294,400 Bristol-Myers Squibb (NYSE:BMY)

Point72 Europe London LLP Buys 162,962 Shares of Bristol-Myers Squibb (NYSE:BMY)

Point72 Europe London LLP Boosts Holdings in Bristol-Myers Squibb (NYSE:BMY)

New England Asset Management Inc. Sells 7,600 Shares of Bristol-Myers Squibb (NYSE:BMY)

LMR Partners LLP Decreases Holdings in Bristol-Myers Squibb (NYSE:BMY)

Janus Henderson Group PLC Has $134.43 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)

Focus Partners Wealth Buys 34,466 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Receives Consensus Rating of "Hold" from Analysts

Bristol-Myers Squibb (NYSE:BMY) Trading Up 1.9% - Time to Buy?

'You Have to Punch the Bully in the Nose': Newly Retired Bristol Myers Squibb GC Calls Law Firms That Settled With Trump Naive

29,939 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Mufg Securities Americas Inc.

Integral Health Asset Management LLC Has $19.80 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Multiple Myeloma Treatment Market Horizons: Bridging Innovation and Growth 2025-2032 | Taiwan News | May. 14, 2025 03:12
Why Bristol-Myers Squibb Company (BMY) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom

Drug firms to pay Hawaii $700 million to settle blood thinner lawsuit

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Jefferies Financial Group Inc.

Bristol-Myers Squibb (NYSE:BMY) is Kahn Brothers Group Inc.'s 4th Largest Position

Gotham Asset Management LLC Sells 61,467 Shares of Bristol-Myers Squibb (NYSE:BMY)

Focus Partners Wealth Boosts Stock Position in Bristol-Myers Squibb (NYSE:BMY)

CHD1 status drives divergent metabolic pathways in SPOP-mutant prostate cancer
BristolMyers news
Latest news
Show more
Tempus stock: TEM stock drops after short seller questions revenue sources

Gap Lists Tariff Costs: Gap Stock Falls After Retailer Forecasts Flat Sales